No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-21 | EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration - Slideshow · seeking_alpha |
| 2026-10-20 | EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals · pr_newswire_finance |
| 2026-10-20 | EyePoint halves workforce and ends Phase III trial early after endpoint miss · yf_tkr_REGN |
| 2026-10-20 | RBC Capital cuts EyePoint stock price target on trial miss · investing_com |
| 2026-10-19 | EyePoint, Inc. Stock 12‑Month Price Target Cut to $20.89, Implies 599% Upside · TradingView |
| 2026-10-19 | EyePoint: Stock Takes Shellacking On Second Pivotal Eye Disease Study Miss · seeking_alpha |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。